Andrei I. Chapoval

5.3k citations

60 papers · 4.4k indexed · 2 hit papers · h-index 25

Immunology top 0.5%
- Immunotherapy and Immune Responses 32
- Immune Cell Function and Interaction 25
- T-cell and B-cell Immunology 23
- Immune Response and Inflammation 7
- Immune cells in cancer 5
Oncology top 1%
- CAR-T cell therapy research 14
- Cancer Immunotherapy and Biomarkers 11
Immunology and Allergy top 5%
Cancer Research top 10%
Genetics top 10%
Radiology, Nuclear Medicine and Imaging
- Monoclonal and Polyclonal Antibodies Research 13

Co-authors: Lieping Chen Koji Tamada Gefeng Zhu Dallas B. Flies Jian Ni Ryan A. Wilcox Gabriel Sica Scott E. Strome
Cited by: Immunology Oncology Immunology and Allergy
Partner nations: United States Russia China

In The Last Decade

Andrei I. Chapoval

58 papers receiving 4.3k citations

Hit Papers

align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2003 B7-H4, a Molecule of the B7 Family, Negatively Regulates T Cell Immunity
2001 B7-H3: A costimulatory molecule for T cell activation and IFN-γ production

Peers

Countries citing papers authored by Andrei I. Chapoval

Since Specialization

Citations

This map shows the geographic impact of Andrei I. Chapoval's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrei I. Chapoval with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrei I. Chapoval more than expected).

Fields of papers citing papers by Andrei I. Chapoval

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrei I. Chapoval. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrei I. Chapoval. The network helps show where Andrei I. Chapoval may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Andrei I. Chapoval, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Andrei I. Chapoval Line = papers co-authored together Andrei I. Chapoval links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Multiple treatment interruptions and protecting HIV-specific CD4 T cells enable durable CD8 T cell response and viral control Anshika Jain,Gaspar E. Cánepa,Mei-Ling Liou,Emily L. Fledderman,Andrei I. Chapoval,Lingzhi Xiao,Ipsita Mukherjee,Bushirat M. Balogun,Hellen Huaman-Vergara,Jeffrey A. Galvin,Princy Kumar,José Bordón,Marcus A. Conant,Jefferey S. Boyle	2024	1
2	The effect of thioredoxin and prochymosin coexpression on the refolding of recombinant alpaca chymosin S. V. Belenkaya,Д. Н. Щербаков,Andrei I. Chapoval,Т. И. Есина,V. V. Elchaninov	2023	0
3	Can Modern Molecular Modeling Methods Help Find the Area of Potential Vulnerability of Flaviviruses? Daniil V. Shanshin,Sophia S. Borisevich,Alexander A. Bondar,Yuri B. Porozov,Elena A. Rukhlova,Е. В. Протопопова,Nikita D. Ushkalenko,В. Б. Локтев,Andrei I. Chapoval,A. A. Ilyichev,Д. Н. Щербаков	2022	5
4	Recent advances in potentiometric biosensing Nicole L. Walker,Anastasiya B. Roshkolaeva,Andrei I. Chapoval,Jeffrey E. Dick	2021	49
5	BTNL8, a butyrophilin-like molecule that costimulates the primary immune response Andrei I. Chapoval,Glennda Smithson,Linda Brunick,Mehdi Mesri,Ferenc Boldog,David P. Andrew,Nikolai V. Khramtsov,Elena A Feshchenko,Gary C. Starling,Peter Mézeš	2013	27
6	Interleukin-7 Inhibits Tumor-Induced CD27−CD28− Suppressor T Cells: Implications for Cancer Immunotherapy Yue Zhang,Lukas W. Pfannenstiel,Elzbieta Bolesta,Carolina L. Montes,Xiaoyu Zhang,Andrei I. Chapoval,Ronald B. Gartenhaus,Scott E. Strome,Brian Gastman	2011	28
7	Repertoire Development and the Control of Cytotoxic/Effector Function in Human γδ T Cells Elizabeth Urban,Andrei I. Chapoval,C. David Pauza	2010	28
8	CD137 Promotes Proliferation and Survival of Human B Cells Xiaoyu Zhang,Caroline Voskens,Michelle A. Sallin,Amudhan Maniar,Carolina L. Montes,Yue Zhang,Wei Lin,Guoyan Li,Erin Burch,Ming Tan,Ronna Hertzano,Andrei I. Chapoval,Koji Tamada,Brian Gastman,Dan H. Schulze,Scott E. Strome	2009	54
9	FcγRIIIa polymorphisms and cetuximab induced cytotoxicity in squamous cell carcinoma of the head and neck Rodney J. Taylor,Siaw‐Lin Chan,Aaron Wood,Caroline Voskens,Jeffrey S. Wolf,Wei Lin,Andrei I. Chapoval,Dan H. Schulze,Guo‐Liang Tian,Scott E. Strome	2008	81
10	B7-H3 Enhances Tumor Immunity In Vivo by Costimulating Rapid Clonal Expansion of Antigen-Specific CD8+ Cytolytic T Cells Liqun Luo,Andrei I. Chapoval,Dallas B. Flies,Gefeng Zhu,Fumiya Hirano,Shengdian Wang,Julie S. Lau,Haidong Dong,Koji Tamada,Andrew S. Flies,Yang Liu,Lieping Chen	2004	152
11	Provision of antigen and CD137 signaling breaks immunological ignorance, promoting regression of poorly immunogenic tumors Ryan A. Wilcox,Dallas B. Flies,Gefeng Zhu,Aaron J. Johnson,Koji Tamada,Andrei I. Chapoval,Scott E. Strome,Larry R. Pease,Lieping Chen	2002	185
12	Provision of antigen and CD137 signaling breaks immunological ignorance, promoting regression of poorly immunogenic tumors Ryan A. Wilcox,Dallas B. Flies,Gefeng Zhu,Aaron J. Johnson,Koji Tamada,Andrei I. Chapoval,Scott E. Strome,Larry R. Pease,Lieping Chen	2002	9
13	Allergic Inflammatory Response to Short Ragweed Allergenic Extract in HLA-DQ Transgenic Mice Lacking CD4 Gene Svetlana P. Chapoval,Koji Iijima,Eric Marietta,Michele Smart,Andrei I. Chapoval,Amy G. Andrews,Chella S. David	2002	14
14	Cutting Edge: Expression of Functional CD137 Receptor by Dendritic Cells Ryan A. Wilcox,Andrei I. Chapoval,Kevin Gorski,Mizuto Otsuji,Tahiro Shin,Dallas B. Flies,Koji Tamada,Robert S. Mittler,Haruo Tsuchiya,Drew M. Pardoll,Lieping Chen	2002	189
15	Provision of antigen and CD137 signaling breaks immunological ignorance, promoting regression of poorly immunogenic tumors Ryan A. Wilcox,Dallas B. Flies,Gefeng Zhu,Aaron J. Johnson,Koji Tamada,Andrei I. Chapoval,Scott E. Strome,Larry R. Pease,Lieping Chen	2002	219
16	Modulation of T-cell-mediated immunity in tumor and graft-versus-host disease models through the LIGHT co-stimulatory pathway Koji Tamada,Koji Shimozaki,Andrei I. Chapoval,Gefeng Zhu,Gabriel Sica,Dallas B. Flies,T. Boone,Hailing Hsu,Yang‐Xin Fu,Shigekazu Nagata,Jian Ni,Lieping Chen	2000	269
17	Induction of antitumor immunity after cure of pulmonary metastases, using staphylococcal enterotoxin B and bispecific antibody David C. Rice,Andrei I. Chapoval,Louis Porter,Heidi D Nelson	1999	2
18	CSF-1 (M-CSF) Enhances the Inflammatory Response of Fibronectin-Primed Macrophages: Pathways Involved in Activation of the Cytokine Network Sergey G. Kremlev,Andrei I. Chapoval,Robert L. Evans	1998	9
19	Differential Sensitivity of Mouse Mononuclear Phagocytes to CSF-1 and LPS: The Potentialin VivoRelevance of Enhanced IL-6 Gene Expression Sonya Kamdar,Andrei I. Chapoval,Jessica Phelps,Jane A. Fuller,Robert Evans	1996	17
20	Bifunctional Antibody Retargeting In Vivo-Activated T Lymphocytes: Simplifying Clinical Application Andrei I. Chapoval,Heidi Nelson,Claude Thibault,Christopher Penna,Phillip A. Dean	1995	5

About Andrei I. Chapoval

Andrei I. Chapoval is a scholar working on Immunology, Oncology and Radiology, Nuclear Medicine and Imaging, having authored 60 papers that have together received 4.4k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (32 papers), Immune Cell Function and Interaction (25 papers), T-cell and B-cell Immunology (23 papers), CAR-T cell therapy research (14 papers), Monoclonal and Polyclonal Antibodies Research (13 papers), Cancer Immunotherapy and Biomarkers (11 papers), Immune Response and Inflammation (7 papers) and Immune cells in cancer (5 papers). The work is most often cited by research in Immunology (3.4k citations), Oncology (2.0k citations) and Immunology and Allergy (105 citations). Andrei I. Chapoval has collaborated with scholars based in United States, Russia and China. Frequent co-authors include Lieping Chen, Koji Tamada, Gefeng Zhu, Dallas B. Flies, Jian Ni, Ryan A. Wilcox, Gabriel Sica, Scott E. Strome, Haidong Dong and Julie S. Lau.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact